Psycheceutical Bioscience

Psycheceutical Bioscience LT Debt/Equity

The Long-Term Debt to Equity Ratio of Psycheceutical Bioscience (BWVI) as of Nov 5, 2026 is -0.26. In the previous year, Long-Term Debt to Equity Ratio was -0.29 — a change of -8.16% (higher).

LT Debt/Equity

-0.26

YoY

-8.16%

Last updated:

Long-Term Debt to Equity Ratio of Psycheceutical Bioscience is 2017 -0.26 . Long-Term Debt to Equity Ratio of Psycheceutical Bioscience was 2016 -0.29 . It decreases by -8.16% higher compared to the previous year.

The Psycheceutical Bioscience LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2014
-0.86 USD
Jan 1, 2015
-0.42 USD
Jan 1, 2016
-0.29 USD
Jan 1, 2017
-0.26 USD
The Psycheceutical Bioscience LT Debt/Equity history
YEARLT Debt/EquityYoY
-0.26-8.16%
-0.29-32.38%
-0.42-50.57%
-0.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psycheceutical Bioscience Stock analysis

What does Psycheceutical Bioscience do? Blue Water Ventures International Inc (BWVI) is a company specialized in the exploration of treasures on the seabed. The company's history dates back to 2005 when founder Keith Webb had the idea to search for lost treasures at sea. Since then, BWVI has become a leading company in the industry. BWVI's business model is based on treasure hunting at sea. The company uses state-of-the-art technologies to locate shipwrecks and other treasures on the ocean floor. Once a treasure is discovered, BWVI forms partnerships with other companies to recover and market the treasure. The profits from the sale of the treasure are divided between BWVI and its partners. BWVI also owns and operates its own online auction where antiques such as jewelry, historical coins, and artifacts are exhibited and sold. The auction is an important part of BWVI's business model and offers customers the opportunity to acquire unique treasures. The company has various divisions all focused on underwater treasure hunting. One division focuses on the exploration and search for sunken ships and artifacts. Another division focuses on the exploration of sites where potential treasures are suspected. BWVI utilizes state-of-the-art technologies such as sonar and magnetic sensors to locate underwater treasures. BWVI also offers services such as archiving and restoration of artifacts. The company collaborates with experts to ensure the best possible preservation and restoration of historical artifacts. BWVI's portfolio includes a variety of products and services. These include unique treasures such as jewels, gold and silver coins, ceramics, and other artifacts recovered from historical shipwrecks. Additionally, the company also offers merchandising items such as t-shirts, caps, and keychains featuring the BWVI logo. Recently, BWVI has also begun to explore other business areas. The company has partnered with a CBD product manufacturer and will be bringing CBD products to the market. Furthermore, BWVI has plans to enter the field of renewable energies, particularly tidal power plants. Overall, BWVI has undergone an impressive development in recent years. The company has established itself as a leading player in underwater treasure hunting and offers its customers a unique experience. With a strong portfolio of products and services and a clear vision for the future, BWVI is well-positioned to continue its success in the future. Psycheceutical Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psycheceutical Bioscience stock

Long-Term Debt to Equity Ratio of Psycheceutical Bioscience is -0.26 in 2017.

Long-Term Debt to Equity Ratio of Psycheceutical Bioscience changed from -0.29 to -0.26, representing a -8.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Psycheceutical Bioscience since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Psycheceutical Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Psycheceutical Bioscience

All Key Metrics — Psycheceutical Bioscience